Trupanion, Inc. (NASDAQ:TRUP) Shares Sold by Steward Partners Investment Advisory LLC

Steward Partners Investment Advisory LLC lowered its position in shares of Trupanion, Inc. (NASDAQ:TRUPGet Rating) by 69.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,565 shares of the financial services provider’s stock after selling 3,618 shares during the period. Steward Partners Investment Advisory LLC’s holdings in Trupanion were worth $139,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Goldman Sachs Group Inc. boosted its stake in Trupanion by 41.0% in the fourth quarter. Goldman Sachs Group Inc. now owns 231,780 shares of the financial services provider’s stock valued at $30,602,000 after acquiring an additional 67,442 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its stake in Trupanion by 2.1% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 251,682 shares of the financial services provider’s stock valued at $33,230,000 after acquiring an additional 5,061 shares in the last quarter. First Republic Investment Management Inc. boosted its stake in Trupanion by 78.9% in the fourth quarter. First Republic Investment Management Inc. now owns 8,014 shares of the financial services provider’s stock valued at $1,058,000 after acquiring an additional 3,535 shares in the last quarter. CIBC Asset Management Inc acquired a new position in Trupanion in the fourth quarter valued at $212,000. Finally, Citigroup Inc. boosted its stake in Trupanion by 69.6% in the fourth quarter. Citigroup Inc. now owns 31,752 shares of the financial services provider’s stock valued at $4,192,000 after acquiring an additional 13,033 shares in the last quarter. Institutional investors and hedge funds own 83.62% of the company’s stock.

Insider Buying and Selling

In related news, CEO Darryl Rawlings sold 4,000 shares of the stock in a transaction dated Tuesday, July 26th. The shares were sold at an average price of $64.21, for a total transaction of $256,840.00. Following the completion of the transaction, the chief executive officer now directly owns 857,109 shares of the company’s stock, valued at $55,034,968.89. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, President Margaret Tooth sold 1,000 shares of the stock in a transaction dated Friday, May 13th. The shares were sold at an average price of $66.71, for a total transaction of $66,710.00. Following the completion of the transaction, the president now directly owns 34,880 shares of the company’s stock, valued at $2,326,844.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Darryl Rawlings sold 4,000 shares of the stock in a transaction dated Tuesday, July 26th. The shares were sold at an average price of $64.21, for a total transaction of $256,840.00. Following the completion of the transaction, the chief executive officer now directly owns 857,109 shares of the company’s stock, valued at $55,034,968.89. The disclosure for this sale can be found here. Insiders sold 21,700 shares of company stock valued at $1,368,070 over the last ninety days. Corporate insiders own 6.77% of the company’s stock.

Trupanion Price Performance

Shares of NASDAQ:TRUP opened at $64.31 on Tuesday. The company has a 50-day simple moving average of $62.65 and a 200-day simple moving average of $75.39. Trupanion, Inc. has a one year low of $50.81 and a one year high of $158.25. The company has a debt-to-equity ratio of 0.16, a quick ratio of 1.88 and a current ratio of 1.88. The stock has a market capitalization of $2.62 billion, a price-to-earnings ratio of -81.40 and a beta of 2.02.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on TRUP. Piper Sandler decreased their price objective on shares of Trupanion from $95.00 to $80.00 and set an “overweight” rating for the company in a research note on Friday, May 27th. Canaccord Genuity Group decreased their price objective on shares of Trupanion from $140.00 to $100.00 in a research note on Friday, April 29th. Bank of America reduced their target price on shares of Trupanion from $118.00 to $110.00 and set a “buy” rating for the company in a report on Wednesday, April 20th. Finally, TheStreet cut shares of Trupanion from a “c-” rating to a “d+” rating in a report on Wednesday, April 6th.

Trupanion Profile

(Get Rating)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Further Reading

Want to see what other hedge funds are holding TRUP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Trupanion, Inc. (NASDAQ:TRUPGet Rating).

Institutional Ownership by Quarter for Trupanion (NASDAQ:TRUP)

Want More Great Investing Ideas?

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.